Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion

Abstract

BackgroundThe vaginal microbiota of healthy women consists of a wide variety of anaerobic and aerobic bacterial genera and species dominated by the genus Lactobacillus. The activity of lactobacilli helps to maintain the natural healthy balance of the vaginal microbiota. This role is particularly important during pregnancy because vaginal dismicrobism is one of the most important mechanisms for preterm birth and perinatal complications. In the present study, we characterized the impact of a dietary supplementation with the probiotic VSL#3, a mixture of Lactobacillus, Bifidobacterium and Streptococcus strains, on the vaginal microbiota and immunological profiles of healthy women during late pregnancy.ResultsAn association between the oral intake of the probiotic VSL#3 and changes in the composition of the vaginal microbiota of pregnant women was revealed by PCR-DGGE population profiling. Despite no significant changes were found in the amounts of the principal vaginal bacterial populations in women administered with VSL#3, qPCR results suggested a potential role of the probiotic product in counteracting the decrease of Bifidobacterium and the increase of Atopobium, that occurred in control women during late pregnancy. The modulation of the vaginal microbiota was associated with significant changes in some vaginal cytokines. In particular, the decrease of the anti-inflammatory cytokines IL-4 and IL-10 was observed only in control women but not in women supplemented with VSL#3. In addition, the probiotic consumption induced the decrease of the pro-inflammatory chemokine Eotaxin, suggesting a potential anti-inflammatory effect on the vaginal immunity.ConclusionDietary supplementation with the probiotic VSL#3 during the last trimester of pregnancy was associated to a modulation of the vaginal microbiota and cytokine secretion, with potential implications in preventing preterm birth.Trial registrationClinicalTrials.gov NCT01367470

Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial

“…and Lac1/Lac2-GC [31] for Lactobacillus group. Amplicons were analyzed by DGGE as previously described [32]. Amplified DNA from probiotics of Psyllogel Megafermenti Ò was run as a standard lane marker.…”

The Rationale for Probiotics Improving Reproductive Health and Pregnancy Outcome

“…87 The realization that babies born by Cesarean section and those fed formula milk have different microbiomes than those born vaginally and fed human milk 7 could result in purposely colonizing Cesarean born infants with the mother's vaginal microbes or multispecies probiotic derived from them. The application of multistrain probiotics to improve pregnancy outcomes has already been tested in a pilot study, with some success in terms of modulating immune parameters and the vaginal microbiota, 88 while the addition of single probiotic strains to infant formula has been approved in many countries and has been reported to increase sIgA levels in the infant. 89 If probiotic products are shown to reduce the risk of preterm labor, preeclampsia and/or gestational cardiovascular or metabolic diseases and to improve infant cognitive function and health, the implications are enormous.…”

The impact of oral probiotics on vaginal Group B Streptococcal colonisation rates in pregnant women: A pilot randomised control study

“…Studies continues to support the positive potential of probiotics to modulate the vaginal microbiota. It will be interesting to discover which strain or combination of strains emerge as the best choice for vaginal health through future research (Ehrstrom et al, 2010;Marcone et al, 2010;Stojanovic et al, 2012;Vitali et al, 2012;Wang et al, 2010).…”